MedPath
HSA Approval

BREACOL COUGH SYRUP 100 mg/5 ml

SIN08411P

BREACOL COUGH SYRUP 100 mg/5 ml

BREACOL COUGH SYRUP 100 mg/5 ml

November 2, 1995

A. MENARINI SINGAPORE PTE. LTD.

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

A. MENARINI SINGAPORE PTE. LTD.

A. MENARINI SINGAPORE PTE. LTD.

Therapeutic

General Sale List

Formulation Information

SYRUP

**Dosage** Adults and children above 12 years --- 2 x 5ml spoonfuls. Repeat 3 times a day.

ORAL

Medical Information

**Indication** Breacol is indicated as an expectorant for symptomatic relief of cough due to colds and upper respiratory tract infection.

R05CA03

guaifenesin

Manufacturer Information

A. MENARINI SINGAPORE PTE. LTD.

PHARMANIAGA MANUFACTURING BERHAD

PT. MENARINI INDRIA LABORATORIES

Active Ingredients

GUAIFENESIN

100 mg/5 ml

Guaifenesin

Documents

Patient Information Leaflets

2019MEN-0169-1 Breacol Cough Syrup Insert SG 12 June 2019.pdf

Approved: July 2, 2020

Download
© Copyright 2025. All Rights Reserved by MedPath